Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety ...

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Bayer (BAYRY) announced the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety of 52mg ...

An oral dose of 100 mg progesterone in a bioidentical hormone therapy combination that includes estradiol is sufficient to counteract potential estrogenic stimulation of the endometrium while ...

Malignant diseases are the second leading cause of death in women. [1] With an incidence of 24 in 100,000, endometrial cancer is the fourth most common cancer in women. [2] When diagnosed at an early ...

Tamoxifen treatment for premenopausal women with breast cancer is independently associated with an increased risk of endometrial cancer and other uterine diseases, according to findings from a large ...

Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...

When to do an endometrial biopsy A patient continues to have breakthrough bleeding while taking oral contraceptives, despite changing pills. What could be the cause? I have a patient in her early 20s ...

Berlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system ...